CJC-1295 (No DAC) – GHRH Analog for Growth Hormone Rhythm Research
CJC-1295 (No DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog widely studied in endocrine research for its role in supporting natural pulsatile growth hormone signaling. Unlike DAC-modified versions, CJC-1295 (No DAC) is investigated for its shorter activity window, making it valuable in studies focused on physiological GH rhythm patterns and receptor interaction timing.
This peptide is commonly utilized in laboratory models examining growth hormone pathways, cellular regeneration processes, and metabolic balance. Its precise mechanism of action has made CJC-1295 (No DAC) a preferred research compound for investigations into recovery biology, body composition regulation, and endocrine system dynamics.
Researchers frequently explore CJC-1295 (No DAC) in studies related to:
- Growth hormone pulsatility and GHRH receptor signaling
- Cellular regeneration and recovery research
- Metabolic function and body composition models
- Endocrine rhythm and hormone regulation studies
- Performance and recovery pathway investigations
CJC-1295 (No DAC) remains a key peptide in growth hormone axis research due to its well-characterized interaction with GHRH receptors and its relevance to physiological hormone timing.
For laboratory research use only. Not for human consumption.
